HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aya Kakizaki Selected Research

Peplomycin

1/2017Retrospective Investigation of Cutaneous Squamous Cell Carcinoma on the Lip Treated with Peplomycin Administered Through a Superficial Temporal Artery.
1/2015Immunomodulatory effects of peplomycin on immunosuppressive and cytotoxic cells in the lesional skin of cutaneous squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aya Kakizaki Research Topics

Disease

14Neoplasms (Cancer)
01/2018 - 01/2013
6Melanoma (Melanoma, Malignant)
01/2018 - 11/2015
4Mycosis Fungoides
09/2016 - 11/2013
2Autoimmune Diseases (Autoimmune Disease)
01/2018 - 09/2012
2Bullous Pemphigoid (Pemphigoid)
12/2017 - 01/2014
2Pemphigus (Pemphigus Vulgaris)
12/2017 - 01/2014
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 01/2015
2Fibrosis (Cirrhosis)
01/2017 - 01/2015
1Vitiligo
04/2018
1Adenocarcinoma
01/2018
1Extramammary Paget Disease (Paget Disease, Extramammary)
01/2018
1Adrenocorticotropic hormone deficiency
03/2017
1Benign Fibrous Histiocytoma (Dermatofibroma)
01/2017
1Dermatofibrosarcoma
01/2017
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
09/2016
1Inflammation (Inflammations)
01/2016
1Moyamoya Disease (Moya-Moya Disease)
01/2016
1Rheumatoid Arthritis
05/2015
1Drug Eruptions (Drug Eruption)
05/2015
1Psoriasis (Pustulosis Palmaris et Plantaris)
05/2015
1Localized Scleroderma (Morphea)
01/2015
1Hypohidrosis
11/2013
1Hemangiosarcoma (Angiosarcoma)
01/2013
1Pain (Aches)
09/2012
1Erythromelalgia (Erythermalgia)
09/2012
1Erythema
09/2012
1Aplastic Anemia (Anemia, Hypoplastic)
09/2012
1Rare Diseases (Rare Disease)
09/2012

Drug/Important Bio-Agent (IBA)

6PeriostinIBA
12/2017 - 01/2015
4ChemokinesIBA
01/2018 - 11/2015
3CytokinesIBA
01/2018 - 01/2017
3NivolumabIBA
09/2017 - 06/2016
2Matrix Metalloproteinases (MMPs)IBA
01/2018 - 01/2017
2Messenger RNA (mRNA)IBA
01/2018 - 11/2015
2RANK LigandIBA
01/2018 - 01/2016
2PeplomycinIBA
01/2017 - 01/2015
2Biological ProductsIBA
09/2016 - 05/2015
2Therapeutic UsesIBA
06/2016 - 11/2015
1Vitamin DFDA LinkGeneric
04/2018
1hydroxide ionIBA
04/2018
1Cholecalciferol (Vitamin D3)FDA Link
04/2018
1rhododendrolIBA
04/2018
1Dacarbazine (DIC)FDA LinkGeneric
01/2018
1Vincristine (Oncovin)FDA LinkGeneric
01/2018
1Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
01/2018
1DenosumabFDA Link
01/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1NimustineIBA
01/2018
1AntibodiesIBA
09/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1Imiquimod (Aldara)FDA LinkGeneric
01/2017
1STAT5 Transcription FactorIBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1Interferon-alpha (Interferon Alfa)IBA
09/2016
1Interferon-gamma (Interferon, gamma)IBA
09/2016
1squaric acidIBA
06/2016
1diphenylcyclopropenoneIBA
06/2016
1HaptensIBA
06/2016
1Interleukin-4 (Interleukin 4)IBA
02/2016
1methyl 4-formylphenyl phosphateIBA
01/2016
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
01/2016
1Interferon-betaIBA
11/2015
1Abatacept (Orencia)FDA Link
05/2015
1Interleukin-13IBA
01/2014
1InterleukinsIBA
01/2014
1dermcidinIBA
11/2013
1RetinoidsIBA
11/2013
1VorinostatFDA Link
11/2013
1Starch (Cornstarch)IBA
11/2013
1IodineIBA
11/2013
1ArginaseIBA
01/2013
1Docetaxel (Taxotere)FDA Link
01/2013
1Risedronic Acid (Actonel)FDA LinkGeneric
01/2013
1Methylprednisolone Hemisuccinate (A-MethaPred)FDA LinkGeneric
09/2012
1Interleukin-17 (Interleukin 17)IBA
09/2012
1Pregabalin (Lyrica)FDA Link
09/2012
1SteroidsIBA
09/2012

Therapy/Procedure

6Therapeutics
01/2018 - 09/2012
2Immunotherapy
09/2016 - 06/2016
1Combination Drug Therapy (Combination Chemotherapy)
01/2018
1Indwelling Catheters (Indwelling Catheter)
01/2015
1Intravenous Administration
09/2012